Evidence map›Paper›PMID 34378531›Full record

ArticleeLife2021

Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome.

Isabelle J Marié, Lara Brambilla, Doua Azzouz, Ze Chen, Gisele V Baracho, Azlann Arnett, Haiyan S Li, Weiguo Liu, Luisa Cimmino, Pratip Chattopadhyay and 4 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. In sickness and in health-Type I interferon and the brain.Frontiers in aging neuroscience · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Isabelle J MariéNYU School of Medicine, New York, United States.ORCID 0000-0002-3091-7624
Lara BrambillaNYU School of Medicine, New York, United States.
Doua AzzouzNYU School of Medicine, New York, United States.
Ze ChenNYU School of Medicine, New York, United States.
Gisele V BarachoBD Life Sciences, La Jolla, United States.
Azlann ArnettTranslational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, United States.
Haiyan S LiUniversity of Texas MD Anderson Cancer Center, Houston, United States.
Weiguo LiuNYU School of Medicine, New York, United States.
Luisa CimminoSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, United States.
Pratip ChattopadhyayNYU School of Medicine, New York, United States.
Gregg SilvermanNYU School of Medicine, New York, United States.
Stephanie S WatowichUniversity of Texas MD Anderson Cancer Center, Houston, United States.ORCID 0000-0003-1969-659X
Bernard KhorTranslational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, United States.ORCID 0000-0003-4689-5092
David E LevyNYU School of Medicine, New York, United States.ORCID 0000-0002-7320-7788
Indiana University School of MedicineBenaroya Research InstituteThe University of Texas MD Anderson Cancer Center · USUniversity of Miami · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)P50AR070591 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P · 2017 to 2021
$6.7M
SIGNAL TRANSDUCTION PATHWAY IN IFN INDUCED TRANSCRIPTIONR01AI028900 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LEVY, DAVID E · 1990 to 2010
$5.6M
Defining Protective Responses in Hematopoietic Cells Mediated by STAT3 Anti-Inflammatory ActivityR01AI133822 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WATOWICH, STEPHANIE S · 2018 to 2022
$2.1M
NCI NIH HHS P30 CA016087NIAID NIH HHS R01 AI028900NIAID NIH HHS R01 AI133822NIAMS NIH HHS P50 AR070591
6 · The paper itself

Abstract

Maintenance of immune homeostasis involves a synergistic relationship between the host and the microbiome. Canonical interferon (IFN) signaling controls responses to acute microbial infection, through engagement of the STAT1 transcription factor. However, the contribution of tonic levels of IFN to immune homeostasis in the absence of acute infection remains largely unexplored. We report that STAT1 KO mice spontaneously developed an inflammatory disease marked by myeloid hyperplasia and splenic accumulation of hematopoietic stem cells. Moreover, these animals developed inflammatory bowel disease. Profiling gut bacteria revealed a profound dysbiosis in the absence of tonic IFN signaling, which triggered expansion of T

Indexed as

Gastrointestinal MicrobiomeAnimalsDysbiosisFemaleInflammationInterferonsInterleukin-17MiceMice, KnockoutSTAT1 Transcription FactorIl17a protein, mouseInterferonsInterleukin-17Stat1 protein, mouseSTAT1 Transcription Factorhematopoietic stem cellshomeostasisimmunologyinfectious diseaseinflammationinterferonmicrobiologymicrobiomemouseTh17

Identifiers

PMID34378531
PMCPMC8376249
OpenAlexW3154073289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.